High Tower Advisors, LLC Takeda Pharmaceutical CO LTD Transaction History

High Tower Advisors, LLC

$68.3 Billion
Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, High Tower Advisors, LLC holds 122,587 shares of TAK stock, worth $1.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

122,587

Previous 40,934 199.47%

Holding current value

$1.71 Million

Previous $529,000 229.11%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$13.0 - $15.08 $1.06 Million - $1.23 Million	81,653 Added 199.47%	122,587 $1.74 Million
Q2 2024 Aug 13, 2024	SELL	$12.6 - $13.67 $656,749 - $712,521	-52,123 Reduced 56.01%	40,934 $529,000
Q1 2024 May 06, 2024	BUY	$13.89 - $15.04 $122,051 - $132,156	8,787 Added 10.43%	93,057 $1.29 Million
Q4 2023 Feb 12, 2024	BUY	$13.36 - $15.43 $7,348 - $8,486	550 Added 0.66%	84,270 $1.2 Million
Q3 2023 Nov 08, 2023	BUY	$15.03 - $16.32 $186,717 - $202,743	12,423 Added 17.42%	83,720 $1.3 Million
Q2 2023 Aug 14, 2023	BUY	$15.57 - $17.11 $601,796 - $661,318	38,651 Added 118.39%	71,297 $1.12 Million
Q1 2023 May 11, 2023	BUY	$15.28 - $16.48 $94,797 - $102,241	6,204 Added 23.46%	32,646 $538,000
Q4 2022 Feb 08, 2023	BUY	$12.42 - $15.62 $37,446 - $47,094	3,015 Added 12.87%	26,442 $412,000
Q3 2022 Nov 09, 2022	SELL	$12.8 - $28.65 $9,203 - $20,599	-719 Reduced 2.98%	23,427 $304,000
Q2 2022 Aug 10, 2022	SELL	$13.12 - $15.03 $54,841 - $62,825	-4,180 Reduced 14.76%	24,146 $340,000
Q1 2022 May 12, 2022	BUY	$13.54 - $15.35 $26,714 - $30,285	1,973 Added 7.49%	28,326 $404,000
Q4 2021 Feb 10, 2022	SELL	$13.17 - $16.4 $69,274 - $86,263	-5,260 Reduced 16.64%	26,353 $360,000
Q3 2021 Nov 12, 2021	SELL	$16.3 - $17.26 $9,959 - $10,545	-611 Reduced 1.9%	31,613 $512,000
Q2 2021 Aug 06, 2021	BUY	$16.55 - $18.64 $93,772 - $105,614	5,666 Added 21.33%	32,224 $544,000
Q1 2021 May 10, 2021	BUY	$16.71 - $19.9 $61,726 - $73,510	3,694 Added 16.16%	26,558 $485,000
Q4 2020 Feb 10, 2021	SELL	$15.39 - $18.97 $26,686 - $32,893	-1,734 Reduced 7.05%	22,864 $416,000
Q3 2020 Nov 13, 2020	BUY	$17.1 - $19.19 $15,201 - $17,059	889 Added 3.75%	24,598 $440,000
Q2 2020 Aug 10, 2020	BUY	$14.59 - $19.5 $68,485 - $91,533	4,694 Added 24.69%	23,709 $425,000
Q1 2020 May 21, 2020	BUY	$13.02 - $20.31 $44,202 - $68,952	3,395 Added 21.73%	19,015 $293,000
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $7,663 - $9,456	-454 Reduced 2.82%	15,620 $309,000
Q3 2019 Nov 12, 2019	SELL	$16.15 - $17.99 $223,919 - $249,431	-13,865 Reduced 46.31%	16,074 $275,000
Q2 2019 Aug 13, 2019	BUY	$16.58 - $20.49 $15,237 - $18,830	919 Added 3.17%	29,939 $534,000
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $484,634 - $624,510	29,020 New	29,020 $591,000

Others Institutions Holding TAK

# of Institutions

337

Shares Held

73.8M

Call Options Held

1.96M

Put Options Held

165K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.3B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Takeda Pharmaceutical CO LTD Transaction History